Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received a consensus recommendation of “Moderate Buy” from eight research firms currently covering the company. According to MarketBeat Ratings, four analysts have assigned a hold rating, while the remaining four have issued buy ratings.
The average price target over the next year among these analysts stands at $47.40. This figure reflects the potential for growth as brokerages continue to evaluate Astrana’s market position. Recently, several reports have been published regarding the stock’s performance and outlook.
Weiss Ratings reaffirmed a “hold (C-)” rating on Astrana Health shares in a report released on October 10. In the same timeframe, Zacks Research upgraded the stock from a “strong sell” to a “hold” rating, indicating a shift in sentiment among analysts.
Stock Performance and Financial Metrics
As of Thursday, shares of Astrana Health opened at $33.30. The company’s stock has exhibited considerable volatility, with a fifty-day moving average price of $30.09 and a two-hundred-day moving average price of $27.93. Currently, Astrana Health boasts a market capitalization of $1.87 billion, a P/E ratio of 65.30, and a PEG ratio of 0.90. The stock has a beta of 0.80, indicating a lower volatility compared to the broader market.
The company’s shares have fluctuated significantly over the past twelve months, reaching a low of $21.20 and a high of $60.99. Financial indicators show a current ratio of 1.59, a quick ratio of 1.59, and a debt-to-equity ratio of 0.52, suggesting a stable liquidity position.
Recently, Astrana Health reported its quarterly earnings on January 10, 2024. The company achieved earnings per share (EPS) of $0.50 for the quarter, with total revenue reaching $317 million. The organization recorded a return on equity of 3.43% and a net margin of 1.04%. Analysts project that Astrana Health will post an EPS of 1.15 for the current financial year.
Company Overview
Astrana Health, Inc. is a physician-centric, technology-driven healthcare management company based in the United States. It operates through three main segments: Care Partners, Care Delivery, and Care Enablement. The firm leverages its proprietary population health management and healthcare delivery platform to create an integrated, value-based healthcare model that empowers providers within its network to deliver effective care to their patients.
With a focus on innovation and efficiency, Astrana Health aims to enhance the delivery of healthcare services across the nation. As the company continues to navigate the complexities of the healthcare landscape, its strategic initiatives will likely be closely monitored by investors and analysts alike.
For ongoing updates on Astrana Health and related financial news, MarketBeat.com offers a concise daily summary to keep stakeholders informed.
